Molecular alterations in prostate cancer.

Authors:

Cancer Lett 2008 Nov 12;271(1):13-24. Epub 2008 Jun 12.

Gen-Probe Incorporated, San Diego, CA 92121, USA.

Prostate tumors display a range of clinical phenotypes, from indolent to aggressively metastatic. Numerous gene expression profiling studies have been conducted toward the potential molecular staging of these pathologies, however the identification of genetic markers that predict aggressive disease has not yet been demonstrated in the clinical setting. A recent survey of the literature has shown that molecular alterations in prostate carcinomas can occur through a variety of different mechanisms, ranging from upstream epigenetic changes and genetic polymorphisms to downstream modulations through alternative splicing and other post-translational processes, some of which could involve noncoding RNAs. A summary of these results and recommendations for future work are the subject of this review.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.04.047DOI Listing
November 2008
2 Reads

Publication Analysis

Top Keywords

alterations prostate
8
molecular alterations
8
literature molecular
4
prostate carcinomas
4
survey literature
4
carcinomas occur
4
variety mechanisms
4
ranging upstream
4
mechanisms ranging
4
setting survey
4
occur variety
4
disease demonstrated
4
genetic markers
4
identification genetic
4
pathologies identification
4
markers predict
4
predict aggressive
4
upstream epigenetic
4
aggressive disease
4
clinical setting
4

Altmetric Statistics

Similar Publications